We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enhanced Ultra-Sensitive Protocol Detects Parkinson’s Disease Proteins in Extracellular Vesicles in Blood

By LabMedica International staff writers
Posted on 04 Nov 2024

Brain disorders such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) often begin developing well before the onset of noticeable clinical symptoms. More...

Early intervention could potentially slow or halt disease progression, but current methods do not allow for the diagnosis of these disorders at pre-symptomatic stages. For instance, the specific brain lesions associated with PD can only be identified through brain biopsies, which are typically performed posthumously. To address this significant challenge, researchers are exploring the concept of “liquid biopsies,” which facilitate the non-invasive extraction of blood or other bodily fluids for analysis of molecules derived from the brain and other solid tissues.

One particularly promising target in body fluids is “extracellular vesicles” (EVs), which are tiny membrane-bound sacs released by brain cells and other types of cells into surrounding fluids. These vesicles contain various molecules that can be specific to the cell types that produce them, including those from the brain, potentially serving as protected biomarkers for the early detection of Parkinson’s and other neurological diseases. Despite recent advancements, experts in EV research have struggled with determining whether specific biomarker molecules measured in isolated EVs are strictly contained within these vesicles or merely bound to their surface. This uncertainty has hindered their ability to draw clear conclusions about the cargo molecules present in EVs from various tissues.

Now, a collaborative research team, including scientists from the Wyss Institute at Harvard University (Boston, MA, USA), has addressed this issue by incorporating a vital step into an already validated ultra-sensitive protocol. By enzymatically digesting all surface-bound proteins from a purified EV population, they successfully focused on the cargo protected inside the EVs while eliminating non-specific contaminants. Utilizing their improved protocol to measure the PD biomarker ⍺-synuclein in blood, the researchers were able to accurately differentiate the small fraction of protein contained within EVs from the total amount present in blood plasma for the first time. Notably, they combined this advancement with a newly developed ultra-sensitive detection assay for a phosphorylated form of ⍺-synuclein, which increases during the progression of PD and the related Lewy Body Dementia. After analyzing a cohort of patient samples, the researchers found an enrichment of the pathological ⍺-synuclein protein within EVs compared to total plasma. These findings have been published in Proceedings of the National Academy of Sciences (PNAS).

“Research on EVs in our and other groups over the last few decades has steadily advanced our understanding of their complex biology and molecular composition. Yet, the isolation of pure tissue-specific EVs from body fluids like blood or the cerebrospinal fluid surrounding the central nervous system, including the brain, and validating and quantifying their true contents with precise measurements still present formidable technical challenges,” said David Walt, Ph.D. at the Wyss Institute at Harvard University who led the research team. “Our recent work is providing a solution to help fill this technological gap, and gets us closer to being able to obtain EVs free from contamination in order to use them as rich sources for clinical biomarkers, as we show with the example of phosphorylated ⍺-synuclein.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.